| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |